MUNAWAR HAIDER: Open Payments
NPI 1124018155 · BEDFORD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,299 in 122 payments from 30 companies in 2025. Trend: 2023 $2,378 · 2024 $2,410 · 2025 $2,299
Food & beverage: $2,279Education: $20
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 11 | $247 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $226 |
| PFIZER INC. | 12 | $175 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $168 |
| AstraZeneca Pharmaceuticals LP | 8 | $156 |
| Abbott Laboratories | 5 | $123 |
| SK Life Science, Inc. | 4 | $107 |
| Amgen Inc. | 6 | $98 |
| Novo Nordisk Inc | 5 | $91 |
| Eisai Inc. | 3 | $80 |
Products named: CAPLYTA, AUSTEDO XR, Kerendia, REXULTI, FREESTYLE LIBRE 3, PREVNAR 20, AIRSUPRA, Leqembi.
Industry payments across TX — which companies pay providers there.
